Results 181 to 190 of about 17,237 (205)
Some of the next articles are maybe not open access.

Anticardiolipin Antibodies and Polyarteritis Nodosa

Lupus, 1994
A patient with biopsy-diagnosed polyarteritis nodosa showed central nervous system (CNS) involvement and evidence of intrathecal synthesis of immunoglobulins, coincident with very high serum levels of anticardiolipin antibodies (aCL). Cerebral angiography was normal. We suggest that aCL could be directly implicated in the CNS damage.
R, de la Fuente Fernandez, J, Graña Gil
openaire   +2 more sources

Anticardiolipin antibodies

Neurology, 1991
We undertook a prospective study of consecutive patients to determine the frequency of elevated IgG and IgM anticardiolipin antibodies in transient ischemic attack and ischemic stroke and found elevated IgG antibodies in 8.2% (9 of 110) and IgM in 9.1% (10 of 110), only the former being significantly greater than in a healthy control population.
D C, Hess   +5 more
openaire   +2 more sources

Anticardiolipin antibodies and ulcerations of the leg

Journal of the American Academy of Dermatology, 1994
ACA appeared to be significantly associated with venous ulcerations of the leg but not with ulcerations associated with isolated arteritis. None of the patients had typical signs of APS. As for the relation between ACA and venous ulcerations, several hypotheses can be proposed.
A M, Barbaud   +6 more
openaire   +2 more sources

Buerger's disease and anticardiolipin antibodies

Journal of Cardiovascular Medicine, 2009
Thromboangiitis obliterans or Buerger's disease is an occlusive, inflammatory, nonatherosclerotic vascular disease of unknown etiology, which affects mainly the small and medium arteries, veins and nerves. Anticardiolipin antibodies are associated with arterial and venous thrombosis, repetitive miscarriages and thrombocytopenia.
José Maria, Pereira de Godoy   +1 more
openaire   +2 more sources

Functional Effects of Anticardiolipin Antibodies

Lupus, 1996
The ‘lupus anticoagulant’ phenomenon is the best documented functional effect of antiphospholipid (aPL) antibodies, occurring either by inhibition of the prothrombinase and/or Factor X activation reactions. Understanding the mechanism by which aPL antibodies inhibit phospholipid dependent coagulation reactions may yield important clues about their ...
E N, Harris, S S, Pierangeli
openaire   +2 more sources

Anticardiolipin Antibodies and Ocular Disease

Ocular Immunology and Inflammation, 2005
This paper reviews anticardiolipin antibodies and ocular disease. Its aim is to present the latest knowledge regarding the relationship between the two. It focuses mainly on ocular features and treatment, but also describes the epidemiology, main systemic features, immunology, and immunopathology of the antiphospholipid syndrome.
Filipe Vieira, Lima Cabrita   +1 more
openaire   +2 more sources

Anticardiolipin antibodies A review of the literature

Journal of Nurse-Midwifery, 1994
Repeated fetal loss may be a result of a variety of causes. Immunological factors have been implicated in fetal loss, intrauterine growth retardation, preeclampsia, and thrombocytopenia. Anticardiolipin antibodies (ACAs) belong to a family of autoantibodies known as antiphospholipid antibodies.
openaire   +2 more sources

Anticardiolipin antibodies in hemodialysis patients

Transplantation Proceedings, 1999
END-STAGE renal disease (ESRD) patients are known to have a higher frequency of elevated anticardiolipin antibodies (aCL) compared with the general population. The prevalence of elevated aCL in hemodialysis (HD) patients exceeds that of ESRD patients who are on conservative treatment.
N, Ozdemir   +5 more
openaire   +2 more sources

Anticardiolipin Antibodies in Scleroderma

JCR: Journal of Clinical Rheumatology, 2006
Raymond J, Enzenauer   +2 more
openaire   +2 more sources

Anticardiolipin Antibodies and Prostacyclin Synthesis

Thrombosis and Haemostasis, 1987
VIOLI, Francesco   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy